Riku H. Rautsola, PhD
Dr. Riku Rautsola is the Company’s President and CEO, and has more than 20 years of international biopharmaceutical experience. Prior to joining VIRxSYS, Dr. Rautsola was President and CEO of Borean Pharma A/S, a biotechnology company in Denmark specializing in novel, second-generation antibody analogue protein therapeutics. Dr. Rautsola also was CEO of Cosmix Molecular Biologicals, Ltd., and he held various senior executive positions at Boehringer Ingelheim, Beiersdorf and Fresenius, each of which are leading international biopharmaceutical companies. During his career, Dr. Rautsola initiated a program with UNAIDS, WHO, Unicef and the UN for the prevention of Mother-To-Child transmission of HIV. He also co-founded and chaired “Accelerating Access,” the five-company organization (BMS, Boehringer, GSK, Merck, and Roche) focused on providing low-cost HIV treatments in developing countries. Dr. Rautsola has a doctorate in health economics from the University of Munich, Germany.
Return to Management/Board Listing
